“Evaluation of the inhibitory effect of 2,5-Dimethyl-Celecoxib on tamoxifen-sensitive and -resistant human breast cancer cells (MCF-7)” (2026) Clinical Medicine and Pharmacology, 3(1). doi:10.70731/sh45n436.